Craft

Lifecore Biomedical

Stock Price

$5.7

2024-10-29

Market Capitalization

$211.4 M

2024-10-29

Revenue

$75.5 M

FY, 2025

Lifecore Biomedical Summary

Company Summary

Overview
Lifecore Biomedical (formerly known as Landec Corporation) is a company that develops and manufactures sterile injectable pharmaceutical products. It provides injectable-grade sodium hyaluronic acid, formulated and filled syringes and vials for medical applications. The company is also involved in technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies.
Type
Public
Status
Active
Founded
1965
HQ
Chaska, MN, US | view all locations
Website
https://www.lifecore.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Paul Josephs
  • Ryan D. Lake

    Ryan D. Lake, Chief Financial Officer

  • Jackie Klecker

    Jackie Klecker, Executive Vice President, Quality and Development Services

  • Thomas Guldager

    Thomas Guldager, Sr. Vice President, Operations

Operating MetricsView all

Manufacturing Facilities

8

FY, 2019

Owned or Leased Properties

10
33.3%

FY, 2019

Patents (US)

23
11.5%

FY, 2019

LocationsView all

9 locations detected

  • Chaska, MNĀ HQ

    United States

    3515 Lyman Blvd

  • Bowling Green, OH

    United States

    12700 S Dixie Hwy

  • Guadalupe, CA

    United States

    4575 W Main St

  • Hanover, PA

    United States

    26 Industrial Dr

  • Petaluma, CA

    United States

    1997 S McDowell Blvd Suite A

  • Santa Clara, CA

    United States

    5201 Great America Pkwy #232

and 3 others

Lifecore Biomedical Financials

Summary Financials

Revenue (Q1, 2026)
$23.2M
Gross profit (Q1, 2026)
$4.5M
Net income (Q1, 2026)
($15.0M)
Cash (Q1, 2026)
$20.8M
EBIT (Q1, 2026)
($4.7M)
Enterprise value
$196.2M

Footer menu